Trump administration revisits policy to close Medicare drug price negotiation loophole
Drugmakers say new Medicare drug price negotiation proposal would undermine incentive to develop better versions of drugs.
News Search
Search Results
Drugmakers say new Medicare drug price negotiation proposal would undermine incentive to develop better versions of drugs.
She went viral for finishing medical school at 72. On the ‘First Opinion Podcast,’ she talks Caribbean medical school, NPs vs. MDs, and more.
WHO director-general says in the DRC, war and malaria kill more people than Ebola, and people there told him what they want most is peace.
The federal government is now proposing to fundamentally rewire scientific research review for no good reason.
Former CDER head Tracy Beth Høeg previously disagreed with staff on approval of teplizumab for children with stage 3 diabetes.
Trusted religious and traditional leaders need to be engaged immediately as the Ebola outbreak spreads rapidly in the DRC and Uganda.
Researchers analyze brain scans from 12,000 children to reveal how socioeconomic factors like poverty and stress shape neural development.
STAT keeps a promises tracker for Robert F. Kennedy Jr.'s Make America Healthy Again movement — successes, incompletes, fails. Updated June 2026.
Kennedy cited his 'publicly available calendar' as an example of his commitment to transparency. It's never been released, even after repeated FOIA filings
Health care AI company Abridge announced new deals with pharma giant Eli Lilly and chip-maker Nvidia, as it aims to gain an edge in a competitive market.
CDC says alcohol use during pregnancy rose from 13.5% in 2021 to 15% in 2024, shows an issue thought to be from the past is an ongoing health concern.
In rare move, advocacy group buys up remaining stockpile of an investigational drug, Luvelta. Will be offered at no cost for compassionate use by patients.
Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug
Annual ADA convention, normally a staid affair, sees protesters expelled, controversy erupt and apologies issued. STATus Report host Alex Hogan dives in.
At the Healthcare Financial Management Association conference, there was wide agreement that affordability is a major issue. What to do was far less clear.
Applying the biomedical paradigm to long Covid, a contested illness, has resulted in a scientific stalemate.
A new open-access policy has led journals owned by Springer Nature, Wiley, and Elsevier to charge outrageous fees to NIH-funded authors.
NIH floats cap on concurrent grants to diversify funding. Experts call the idea well-intentioned but worry it won't be implemented fairly.
Medicare Advantage insurers block care for seniors only to reverse denials on appeal. A new OIG report exposes a potentially profit-driven tactic.
The American College of Obstetricians and Gynecologists calls for four shots to be routinely administered in pregnancy.
In this edition of STAT's AI Prognosis: Quirky health care data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
Preliminary data suggest a promising path forward for “synthetic lethality” in the treatment of cancer, and could spur some biotech deal-making.
Early data compare favorably to a blockbuster medicine sold by Novartis and an experimental therapy owned by Merck.
STAT's award-winning series and investigations include the Polk-award-winning 'American Science Shattered' and the Pulitzer finalist 'Denied by AI.'